Starship Ventures

Starship Ventures is a San Francisco-based early-stage venture capital firm dedicated to investing in Deep Tech companies. Established with a clear focus on addressing "humanity’s grand challenges of the 21st century," the firm targets innovative startups leveraging scientific discovery and engineering breakthroughs. Their investment thesis spans a broad spectrum of Deep Tech sectors, including artificial intelligence, biotechnology, climate technology, space exploration, robotics, advanced materials, and quantum computing.

Operating primarily at the Seed and Series A stages, Starship Ventures seeks to identify and support foundational technologies with transformative potential. The firm's strategy involves providing capital to companies that are developing solutions for critical global issues, from future health and food systems to sustainable energy and the future of work. With a reported fund size of $10 million for its inaugural fund, Starship Ventures aims to make strategic early bets in high-growth, capital-intensive Deep Tech ventures.

Starship Ventures has built a notable portfolio of companies, demonstrating a keen eye for disruptive innovation. As of early 2024, the firm has made 17 disclosed investments, participating in early rounds for companies that have gone on to achieve significant milestones, including successful IPOs and substantial follow-on funding. Their portfolio includes prominent names like Insilico Medicine, Recursion Pharmaceuticals, Atomwise, and BenevolentAI, all of which operate at the intersection of AI and drug discovery. This track record underscores Starship Ventures' commitment to fostering the development of groundbreaking technologies that promise long-term societal and economic impact.